India and the Patent Wars

Regular price €28.50
Regular price €31.99 Sale Sale price €28.50
A01=Murphy Halliburton
access to medicines
Age Group_Uncategorized
Age Group_Uncategorized
Author_Murphy Halliburton
automatic-update
Category1=Non-Fiction
Category=JHMC
Category=KND
Category=NHF
COP=United States
Delivery_Delivery within 10-20 working days
eq_business-finance-law
eq_history
eq_isMigrated=2
eq_non-fiction
eq_society-politics
global politics of health
India
intellectual property
Language_English
PA=Available
patent law
pharmaceuticals
Price_€20 to €50
PS=Active
public health
SN=The Culture and Politics of Health Care Work
softlaunch

Product details

  • ISBN 9781501713477
  • Weight: 454g
  • Dimensions: 152 x 229mm
  • Publication Date: 15 Nov 2017
  • Publisher: Cornell University Press
  • Publication City/Country: US
  • Product Form: Paperback
  • Language: English
Delivery/Collection within 10-20 working days

Our Delivery Time Frames Explained
2-4 Working Days: Available in-stock

10-20 Working Days
: On Backorder

Will Deliver When Available
: On Pre-Order or Reprinting

We ship your order once all items have arrived at our warehouse and are processed. Need those 2-4 day shipping items sooner? Just place a separate order for them!

India and the Patent Wars contributes to an international debate over the costs of medicine and restrictions on access under stringent patent laws showing how activists and drug companies in low-income countries seize agency and exert influence over these processes. Murphy Halliburton contributes to analyses of globalization within the fields of anthropology, sociology, law, and public health by drawing on interviews and ethnographic work with pharmaceutical producers in India and the United States.

India has been at the center of emerging controversies around patent rights related to pharmaceutical production and local medical knowledge. Halliburton shows that Big Pharma is not all-powerful, and that local activists and practitioners of ayurveda, India’s largest indigenous medical system, have been able to undermine the aspirations of multinational companies and the WTO. Halliburton traces how key drug prices have gone down, not up, in low-income countries under the new patent regime through partnerships between US- and India-based companies, but warns us to be aware of access to essential medicines in low- and middle-income countries going forward.

Murphy Halliburton is Associate Professor of Anthropology at Queens College and the Graduate Center, CUNY. He is the author of Mudpacks and Prozac.